{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:34:16Z","timestamp":1760783656322,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.clinbiochem.2013.03.001","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T07:06:34Z","timestamp":1363158394000},"page":"819-824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Gas chromatography\u2013mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria"],"prefix":"10.1016","volume":"46","author":[{"given":"Gregori","family":"Casals","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3scar J.","family":"Pozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"To-Figueras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0005","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0010","series-title":"The metabolic basis of inherited disease","article-title":"Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias","author":"Anderson","year":"2001"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199201000-00001","article-title":"Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases","volume":"71","author":"Kauppinen","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.md.0000152454.56435.f3","article-title":"An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity","volume":"84","author":"Hift","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0025","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/00365510902935979","article-title":"Clinical aspects of acute intermittent porphyria in northern Sweden: a population-based study","volume":"69","author":"Bylesjo","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJM198409063111006","article-title":"Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone","volume":"311","author":"Anderson","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.33549\/physiolres.930000.55.S2.43","article-title":"(Far) Outside the box: genomic approach to acute porphyria","volume":"55","author":"Thunell","year":"2006","journal-title":"Physiol Res"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2007-1007139","article-title":"Acute porphyrias: pathogenesis of neurological manifestations","volume":"18","author":"Meyer","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(04)15646-8","article-title":"Liver transplantation as a cure for acute intermittent porphyria","volume":"363","author":"Soonawalla","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2796.2009.02118.x","article-title":"Role of two nutritional hepatic markers (insulin-like growth factor 1 and transthyretin) in the clinical assessment and follow-up of acute intermittent porphyria patients","volume":"266","author":"Delaby","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0055","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.metabol.2010.05.016","article-title":"Preliminary report: hyperhomocysteinemia in patients with acute intermittent porphyria","volume":"59","author":"To-Figueras","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0060","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.136.5.1043","article-title":"Studies in porphyria. I. A defect in the reductive transformation of natural steroid hormones in the hereditary liver disease, acute intermittent porphyria","volume":"136","author":"Kappas","year":"1972","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0065","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1084\/jem.138.4.754","article-title":"Studies in porphyria. II. Evidence for a deficiency of steroid delta-4-5-alpha-reductase activity in acute intermittent porphyria","volume":"138","author":"Bradlow","year":"1973","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0070","series-title":"GC\/MS steroid profiling: diagnosis of disorders affecting steroid synthesis and metabolism","first-page":"789","volume":"vol. 8","author":"Shackleton","year":"2006"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0075","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jsbmb.2010.04.010","article-title":"Gas chromatography\/mass spectrometry (GC\/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC\/MS\/MS)","volume":"121","author":"Krone","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2004-814565","article-title":"Gas chromatography\u2013mass spectrometry profiling of steroids in times of molecular biology","volume":"36","author":"Wudy","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0085","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.33549\/physiolres.930000.55.S2.67","article-title":"European porphyria initiative (EPI): a platform to develop a common approach to the management of porphyrias and to promote research in the field","volume":"55","author":"Deybach","year":"2006","journal-title":"Physiol Res"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0090","doi-asserted-by":"crossref","first-page":"422","DOI":"10.12968\/hosp.2001.62.7.1613","article-title":"Treatment of acute porphyria","volume":"62","author":"Elder","year":"2001","journal-title":"Hosp Med"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0095","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0009-8981(84)90192-X","article-title":"Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias","volume":"139","author":"Lim","year":"1984","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0105","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jcp.54.7.500","article-title":"ACP Best Practice No 165: front line tests for the investigation of suspected porphyria","volume":"54","author":"Deacon","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0960-0760(93)90132-G","article-title":"Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research","volume":"45","author":"Shackleton","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0115","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0039-128X(96)00118-9","article-title":"Quantitation of cortisol and related 3-oxo-4-ene steroids in urine using gas chromatography\/mass spectrometry with stable isotope-labeled internal standards","volume":"61","author":"Palermo","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-4347(00)80683-0","article-title":"Profiling steroid hormones and urinary steroids","volume":"379","author":"Shackleton","year":"1986","journal-title":"J Chromatogr"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0120","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clinbiochem.2008.12.027","article-title":"The urinary steroid profile in patients diagnosed with adrenal incidentaloma","volume":"42","author":"Kot\u0142owska","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0125","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1210\/jc.2003-030240","article-title":"Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates","volume":"88","author":"Tsilchorozidou","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00228-003-0690-3","article-title":"Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals","volume":"59","author":"Galteau","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0135","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1600-0412.2012.01536.x","article-title":"Women with acute intermittent porphyria have a defect in 5\u03b1-steroid production during the menstrual cycle","volume":"91","author":"Innala","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0140","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2012.01.028","article-title":"An uncommon option for surviving bariatric surgery: regaining weight!","volume":"125","author":"Danion","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0145","doi-asserted-by":"crossref","first-page":"7646","DOI":"10.1073\/pnas.80.24.7646","article-title":"Nutrition\u2013endocrine interactions: induction of reciprocal changes in the delta 4-5 alpha-reduction of testosterone and the cytochrome P-450-dependent oxidation of estradiol by dietary macronutrients in man","volume":"80","author":"Kappas","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0150","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2337\/db08-0094","article-title":"Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss","volume":"57","author":"Tomlinson","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1054\/clnu.2001.0397","article-title":"Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders","volume":"203","author":"Caregaro","year":"2001","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0160","first-page":"133","article-title":"Steroid excretion in anorexia nervosa patients","volume":"90","author":"Vanluchene","year":"1979","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/endo.133.2.8344190","article-title":"Androgen induction of steroid 5 alpha-reductase may be mediated via insulin-like growth factor-I","volume":"133","author":"Horton","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0170","first-page":"441","article-title":"A simple noninvasive procedure for the investigation of cytochrome P450 IIIA dependent enzymes in humans","volume":"11","author":"Bienvenu","year":"1991","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0175","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2125.1987.tb03059.x","article-title":"Antipyrine metabolism in acute hepatic porphyria in relapse and remission","volume":"23","author":"Birnie","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cpt197619147","article-title":"Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria","volume":"19","author":"Anderson","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0009-8981(90)90169-S","article-title":"Elevation of blood lactate and pyruvate levels in acute intermittent porphyria\u2014a reflection of haem deficiency?","volume":"90","author":"Herrick","year":"1990","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0190","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/clpt.1992.28","article-title":"Rapid normalization of antipyrine oxidation by heme in variegate porphyria","volume":"51","author":"Mustajoki","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinbiochem.2013.03.001_bb0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/beem.2000.0119","article-title":"Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase","volume":"15","author":"Tomlinson","year":"2001","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013000921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912013000921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:41:20Z","timestamp":1757864480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912013000921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0009912013000921"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.03.001","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gas chromatography\u2013mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}